Biomarkers of Nicotine Exposure: Forensic Toxicological Significance, Analytical Methods, and Interpretative Challenges

Blessi Naresh Uikey

Department of Forensic Science, Guru Ghasidas Vishwavidyalaya, Bilaspur, Chhattisgarh, India.

Megha Yadav

Department of Forensic Science, Mandsaur University, Mandsaur, India.

Shantnu Singh Rathore

Department of Forensic Science, Guru Ghasidas Vishwavidyalaya, Bilaspur, Chhattisgarh, India.

Kalyani Kumari

Department of Psychology, Kalinga University, Naya Raipur, Chhattisgarh, India.

Chanchal Kumar *

Department of Forensic Science, Guru Ghasidas Vishwavidyalaya, Bilaspur, Chhattisgarh, India.

*Author to whom correspondence should be addressed.


Abstract

Nicotine exposure may arise from combustible tobacco, smokeless tobacco, electronic nicotine delivery systems, heated tobacco products, nicotine replacement medicines, occupational contact, environmental contamination, or accidental and intentional ingestion. A forensic measurement must therefore address a specific question rather than simply establish whether a nicotine-related compound is present. This narrative review examines nicotine pharmacokinetics, major biomarkers, biological specimens, analytical methods, and the evidentiary boundaries of interpretation. Parent nicotine is most informative about relatively recent exposure but is rapidly redistributed and eliminated. Cotinine offers a longer detection interval, whereas trans-3′-hydroxycotinine and the nicotine metabolite ratio inform metabolic activity. Urinary total nicotine equivalents can characterise nicotine intake more comprehensively in research settings. The tobacco-specific nitrosamine metabolite NNAL provides evidence of exposure to the tobacco-derived precursor NNK over a comparatively prolonged period, although it does not measure nicotine dose or establish a precise exposure date. Blood, urine, saliva, hair, and nails differ in sampling practicality, analyte concentration, temporal resolution, and susceptibility to contamination. Contemporary gas chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry permit sensitive measurement when extraction, calibration, identity criteria, and matrix-specific validation are adequate. The review emphasises that biomarker concentrations cannot independently determine product identity, intent, dependence, impairment, fatal dose, or cause of death. Robust interpretation requires a documented specimen, appropriate analytical quality assurance, an explicit account of competing explanations, and integration with independent clinical and circumstantial evidence. The clinical and forensic utility of multi-analyte strategies is greatest when each component addresses a distinct and supportable inferential question.

Keywords: Nicotine, cotinine, trans-3′-hydroxycotinine, NNAL, forensic toxicology, biomonitoring, LC–MS/MS, biological matrices


How to Cite

Uikey, Blessi Naresh, Megha Yadav, Shantnu Singh Rathore, Kalyani Kumari, and Chanchal Kumar. 2026. “Biomarkers of Nicotine Exposure: Forensic Toxicological Significance, Analytical Methods, and Interpretative Challenges”. Journal of Disease and Global Health 19 (2):529-48. https://doi.org/10.56557/jodagh/2026/v19i211376.

Downloads

Download data is not yet available.